Application Values of Intraaortic Palloon Pumping in the Treatment of Acute Left Heart Failure
10.13241/j.cnki.pmb.2017.22.038
- VernacularTitle:主动脉球囊反搏器植入术治疗急性左心衰的应用价值
- Author:
Mianjun HUANG
;
Jiaxing LIU
;
Congde YANG
;
Zhiwei CAI
;
Xianxue XIE
- Keywords:
Aortic balloon pump implantation;
Acute left heart failure;
Cardiac function;
Recent primary end point event
- From:
Progress in Modern Biomedicine
2017;17(22):4357-4360
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the application values of intraaortic palloon pumping in the treatment of acute left heart failure.Methods:From February 2013 to January 2016,102 patients in our hospital for diagnosis and treatment of acute left heart failure were selected as the research object,all the patients were equally divided into the observation group and control group with 51 patients in each group according to the random draw envelope principle.The control group was given routine drug treatment,the observation group was given intraaortic palloon pumping treatment based on the treatment in control group,the prognosis of two groups were observed and compared between two groups.Results:The total effective rate of observation group and control group were 96.1％ and 84.3 ％,respectively,which was significantly higher in the tobservation group than that of the control group (P＜0.05).The LVEF values in the observation group and control group after treatment were 65.22 ± 4.52 ％ and 58.20 ± 5.31％ respectively,which were significantly higher than those before treatment 45.29± 5.14 ％ and 45.20± 4.89 ％,and the LVEF value of observation group was significantly higher than that of the control group (P＜0.05).After 6 months' treatment,the incidence of death,refractory ischemia,malignant arrhythmia and other recent primary end points in the observation group was 5.9 ％,the control group was 21.6 ％,which was significantly higher than that of the observation group (P＜0.05).Conclusion:Aortic balloon pump implantation could promote the improvement of left ventricular function,improve the treatment effect,reduce the occurrence of recent primary end point event in the treatment of acute left heart failure.
